grant

MATCHMAKERS - Creating and training AI tools for TCR binding prediction and design

Organization MASSACHUSETTS INSTITUTE OF TECHNOLOGYLocation CAMBRIDGE, UNITED STATESPosted 1 May 2024Deadline 30 Apr 2027
NIHUS FederalResearch GrantFY2024AddressAlanineAlgorithmsAntigen PresentationAntigen TargetingAntigensBase SequenceBenchmarkingBest Practice AnalysisBiochemicalBiologyCancer TreatmentCancersCollectionComplexComputer ModelsComputerized ModelsComputing MethodologiesDataData CollectionData SetDevelopmentDrugsEngineeringEventFaceFeedbackGenerationsGenetic AlterationGenetic ChangeGenetic defectGoalsGrantHealthcareHumanImmune mediated therapyImmune responseImmune systemImmunityImmunodominant AntigensImmunological responseImmunologically Directed TherapyImmunologyImmunotherapyIncrease lifespanInstitutionInvestigatorsLibrariesLytotoxicityMHC ReceptorMachine LearningMajor Histocompatibility Complex ReceptorMalignant MelanomaMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant TumorMalignant Tumor of the LungMalignant neoplasm of lungMedicationMelanomaMethodsModelingModern ManMolecularMutationNucleotide SequencePeptide-MHCPeptide-Major Histocompatibility Protein ComplexPeptide/MHC ComplexPeptidesPharmaceutical PreparationsPhysicsProxyPulmonary CancerPulmonary malignant NeoplasmResearch PersonnelResearchersResolutionScanningSightSingle cell seqSourceSpecificityStructural ModelsStructureSystemT cell based therapeuticsT cell based therapyT cell directed therapiesT cell responseT cell targeted therapeuticsT cell therapyT-Cell Antigen Receptor SpecificityT-Cell Antigen ReceptorsT-Cell ReceptorT-Cell Receptor InteractionT-Cell Receptor SpecificityT-Cell Receptor TherapyT-Cell Receptor TreatmentT-Cell Receptor based TherapyT-Cell Receptor based TreatmentT-CellsT-LymphocyteT-cell receptor repertoireT-cell therapeuticsT-cell transfer therapyTCR ActivationTCR InteractionTCR TherapyTCR based TherapyTCR based treatmentTCR repertoireTestingTherapeuticToxic effectToxicitiesTrainingTumor AntigensTumor-Associated AntigenUncertaintyValidationVirusVisionWorkYeastsadoptive T cell transferadoptive T-cell therapyalgorithm developmentalgorithm traininganti-cancer therapybenchmarkcancer antigenscancer therapycancer typecancer-directed therapycheck point blockadecheckpoint blockadecombinatorialcomputational methodologycomputational methodscomputational modelingcomputational modelscomputer based methodcomputer based modelscomputer based predictioncomputer methodscomputerized modelingcomputing methodcross reactivitycytotoxicitydata to traindataset to traindesigndesigningdevelopmentaldoubtdrug/agentelongating the lifespanextend life spanextend lifespanfacesfacialgenome mutationhealth carehost responseimmune check point blockadeimmune checkpoint blockadeimmune system responseimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based therapiesimmune-based treatmentsimmuno therapyimmunogenimmunoresponseimprovedinsightintervention designlarge scale datalarge scale data setslarge scale datasetslifespan extensionlung cancermachine based learningmalignancymethod developmentmouse modelmurine modelneoplasm/cancernew drug classnext generationnovel drug classnucleic acid sequencepMHCpersonalization of treatmentpersonalized medicinepersonalized therapypersonalized treatmentprediction algorithmpredictive modelingquantumreceptor bindingreceptor boundresolutionsresponsesingle cell next generation sequencingsingle cell sequencingstructural biologytherapeutic T-cell platformtherapy designthymus derived lymphocytetooltraining datatreatment designtumortumor-specific antigenvalidationsvisual function
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Abstract
Understanding how T cell receptors (TCRs) see tumor antigens presented by MHCs is necessary to fully

understand how the immune system recognizes tumor antigens, and to reap the full potential of antigen-specific

immunotherapy. To achieve this goal, a quantum leap forward is required in which the revolutionary advances in

machine learning are combined with a large volume of structure, function, data on matched TCR-pMHC pairs.

The development of accurate predictors of TCR-antigen recognition will be dependent on the creation and

integration sequencing-based datasets with high-throughput structural and functional insights. Our proposal,

submitted as a CRUK/NCI Grand Challenge team (MATCHMAKERS) will combine researchers with expertise in

immunology, methods development, structural biology, and computation to enable generalized prediction and

design of TCR recognition. This work will be spread across four Work Packages (WPs):

WP1: Large-scale generation of TCR-pMHC pairs from naturally occurring sources. We will build datasets of

naturally occurring TCR-pMHC pairs. Our team will use an array of approaches to collect these datasets, from

humans and from mouse models, and in the context of both cancer and immunity more generally.

WP2: Ultra-high throughput TCR-pMHC matching using molecular engineering. Efforts to create general models

will require a broader array of data than feasible to collect from natural TCR systems. We will use an array of

synthetic approaches developed by our team to comprehensively match TCRs with pMHCs to train

computational models.

WP3: Large-scale structural and biochemical analyses of TCR-pMHC interactions. A key to our team’s vision is

to match interaction datasets with high throughput structural and functional insights. A deep understanding of

how the TCR contacts with MHC helices control function and orientation will be essential for training and testing

computational models.

WP4 AI-based prediction and design of TCR-pMHC interactions. We will integrate our data to train next-

generation algorithms capable of generally predicting and designing TCR-pMHC interactions. These predictions

will proceed through a reiterative testing and feedback circuits for further model optimization.

Grant Number: 1OT2CA297463-01
NIH Institute/Center: NIH

Principal Investigator: Michael Birnbaum

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →